SCANNING EFFECT

DEAD

Serial Number

74644425

Owner

PACIFIC VISION NETWORK, INC.

Attorney

Marshall G. MacFarlane

First Use Date

Oct 30, 1996

Filing Date

Mar 10, 1995

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

SCANNING EFFECT Trademark

Serial Number: 74644425 • Registration: 2058008

SCANNING EFFECT is a trademark filed by PACIFIC VISION NETWORK, INC. on March 10, 1995. The trademark is classified under Class 9 (Computers & Electronics). The application is currently no longer active.

Trademark Classes

Class 9 - Computers & Electronics

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

Owner Contact Info

PACIFIC VISION NETWORK, INC. (8 trademarks)

115 West Madison
Ann Arbor, MI 48103

Entity Type: 03

Legal Representation

Attorney of Record

Marshall G. MacFarlane

415 trademarks filed View all →

Correspondence Address

MARSHALL G MACFARLANE YOUNG, MACFARLANE & WOOD, PC

3001 W BIG BEAVER RD

STE 624

TROY

MI 48084-3109

Trademark Details

Filing Date

March 10, 1995

Registration Date

April 29, 1997

First Use Anywhere

October 30, 1996

First Use in Commerce

October 30, 1996

Published for Opposition

October 31, 1995

Cancellation Date

January 31, 2004

Filing History

CANCELLED SEC. 8 (6-YR)

Jan 31, 2004 C8..

REGISTERED-PRINCIPAL REGISTER

Apr 29, 1997 R.PR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

Mar 3, 1997 CNPR

STATEMENT OF USE PROCESSING COMPLETE

Feb 21, 1997 SUPC

SOU EXTENSION 2 GRANTED

Feb 13, 1997 EX2G

USE AMENDMENT FILED

Dec 24, 1996 IUAF

SOU EXTENSION 2 FILED

Dec 24, 1996 EXT2

SOU EXTENSION 1 GRANTED

Sep 19, 1996 EX1G

SOU EXTENSION 1 FILED

Jul 18, 1996 EXT1

NOA MAILED - SOU REQUIRED FROM APPLICANT

Jan 23, 1996 NOAM

PUBLISHED FOR OPPOSITION

Oct 31, 1995 PUBO

NOTICE OF PUBLICATION

Oct 2, 1995 NPUB

APPROVED FOR PUB - PRINCIPAL REGISTER

Aug 18, 1995 CNSA

ASSIGNED TO EXAMINER

Aug 17, 1995 DOCK

Related Trademarks

More from this Owner

More in Same Class

DOC-IN-A-BOX

FRONTIER TECHNOLOGIES CORPORATION

CELLCHECK

EPIC

CANCER OUTCOME

SEGASYS